MassMutual Private Wealth & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $485K | Sell |
8,419
-195
| -2% | -$11.2K | 0.01% | 314 |
|
|
2026
Q1 | $522K | Sell |
8,614
-209
| -2% | -$12.2K | 0.01% | 308 |
|
|
2025
Q4 | $476K | Buy |
8,823
+709
| +9% | +$34.1K | 0.01% | 313 |
|
|
2025
Q3 | $366K | Sell |
8,114
-774
| -9% | -$36.1K | 0.01% | 354 |
|
|
2025
Q2 | $411K | Sell |
8,888
-1,143
| -11% | -$56.1K | 0.01% | 348 |
|
|
2025
Q1 | $612K | Buy |
10,031
+1,344
| +15% | +$78.3K | 0.02% | 301 |
|
|
2024
Q4 | $491K | Buy |
8,687
+332
| +4% | +$18.6K | 0.01% | 321 |
|
|
2024
Q3 | $432K | Buy |
8,355
+1,908
| +30% | +$89.5K | 0.01% | 314 |
|
|
2024
Q2 | $268K | Buy |
6,447
+226
| +4% | +$10.1K | 0.01% | 359 |
|
|
2024
Q1 | $337K | Buy |
6,221
+240
| +4% | +$12.2K | 0.01% | 329 |
|
|
2023
Q4 | $307K | Sell |
5,981
-59,721
| -91% | -$3.13M | 0.01% | 328 |
|
|
2023
Q3 | $3.81M | Sell |
65,702
-1,209
| -2% | -$74.1K | 0.14% | 139 |
|
|
2023
Q2 | $4.28M | Buy |
66,911
+55,300
| +476% | +$3.71M | 0.15% | 128 |
|
|
2023
Q1 | $805K | Sell |
11,611
-377
| -3% | -$26.6K | 0.03% | 236 |
|
|
2022
Q4 | $863K | Buy |
11,988
+344
| +3% | +$25.9K | 0.04% | 232 |
|
|
2022
Q3 | $828K | Sell |
11,644
-2,020
| -15% | -$147K | 0.04% | 227 |
|
|
2022
Q2 | $1.05M | Sell |
13,664
-995
| -7% | -$75.8K | 0.05% | 218 |
|
|
2022
Q1 | $1.07M | Sell |
14,659
-587
| -4% | -$39.4K | 0.04% | 225 |
|
|
2021
Q4 | $951K | Sell |
15,246
-1,336
| -8% | -$78.4K | 0.04% | 244 |
|
|
2021
Q3 | $981K | Buy |
16,582
+1,401
| +9% | +$92.3K | 0.04% | 230 |
|
|
2021
Q2 | $1.01M | Buy |
15,181
+11
| +0.1% | +$717 | 0.04% | 229 |
|
|
2021
Q1 | $958K | Sell |
15,170
-854
| -5% | -$53.1K | 0.05% | 229 |
|
|
2020
Q4 | $994K | Buy |
16,024
+209
| +1% | +$12.9K | 0.05% | 215 |
|
|
2020
Q3 | $953K | Sell |
15,815
-172
| -1% | -$10.4K | 0.06% | 209 |
|
|
2020
Q2 | $940K | Sell |
15,987
-345
| -2% | -$20.6K | 0.06% | 197 |
|
|
2020
Q1 | $910K | Sell |
16,332
-1,241
| -7% | -$75.9K | 0.07% | 185 |
|
|
2019
Q4 | $1.13M | Buy |
17,573
+2,676
| +18% | +$153K | 0.07% | 197 |
|
|
2019
Q3 | $755K | Buy |
14,897
+11,877
| +393% | +$558K | 0.05% | 222 |
|
|
2019
Q2 | $137K | Sell |
3,020
-661
| -18% | -$30.8K | 0.01% | 358 |
|
|
2019
Q1 | $176K | Sell |
3,681
-705
| -16% | -$35.1K | 0.01% | 352 |
|
|
2018
Q4 | $228K | Sell |
4,386
-450
| -9% | -$24.2K | 0.02% | 307 |
|
|
2018
Q3 | $300K | Sell |
4,836
-270
| -5% | -$16K | 0.02% | 310 |
|
|
2018
Q2 | $283K | Buy |
5,106
+26
| +0.5% | +$1.4K | 0.02% | 309 |
|
|
2018
Q1 | $321K | Sell |
5,080
-2,251
| -31% | -$145K | 0.03% | 294 |
|
|
2017
Q4 | $449K | Sell |
7,331
-992
| -12% | -$62K | 0.04% | 248 |
|
|
2017
Q3 | $531K | Sell |
8,323
-742
| -8% | -$43.3K | 0.04% | 226 |
|
|
2017
Q2 | $505K | Sell |
9,065
-2,463
| -21% | -$134K | 0.05% | 218 |
|
|
2017
Q1 | $627K | Sell |
11,528
-17,538
| -60% | -$962K | 0.06% | 205 |
|
|
2016
Q4 | $1.7M | Buy |
+29,066
| New | +$1.59M | 0.21% | 124 |
|
|
2016
Q2 | $2.7M | Buy |
36,746
+3,502
| +11% | +$247K | 0.34% | 88 |
|
|
2016
Q1 | $2.12M | Sell |
33,244
-2,786
| -8% | -$176K | 0.29% | 93 |
|
|
2015
Q4 | $2.48M | Buy |
36,030
+33,986
| +1,663% | +$2.25M | 0.35% | 76 |
|
|
2015
Q3 | $105K | Buy |
2,044
+226
| +12% | +$14.3K | 0.02% | 321 |
|
|
2015
Q2 | $88.2K | Buy |
1,818
+50
| +3% | +$3.29K | 0.02% | 326 |
|
|
2015
Q1 | $114K | Sell |
1,768
-276
| -14% | -$17.3K | 0.02% | 321 |
|
|
2014
Q4 | $121K | Hold |
2,044
| – | – | 0.04% | 209 |
|
|
2014
Q3 | $105K | Buy |
2,044
+377
| +23% | +$18.8K | 0.02% | 314 |
|
|
2014
Q2 | $80.9K | Sell |
1,667
-8,661
| -84% | -$427K | 0.03% | 206 |
|
|
2014
Q1 | $537K | Buy |
10,328
+3,613
| +54% | +$192K | 0.31% | 90 |
|
|
2013
Q4 | $357K | Buy |
+6,715
| New | +$342K | 0.33% | 63 |
|
Other funds holding BMY
AIM
FWIA
DLA
MassMutual Private Wealth & Trust's BMY Position: Q2 2026 in Review
MassMutual Private Wealth & Trust reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q2 2026, selling an estimated $11.2K and leaving 8,419 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #314.
MassMutual Private Wealth & Trust first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.28M in Q2 2023. 954 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- MassMutual Private Wealth & Trust held 8,419 shares of Bristol-Myers Squibb worth $485K as of Q2 2026.
- MassMutual Private Wealth & Trust sold 195 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.2K.
- Bristol-Myers Squibb made up 0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #314 holding.
- MassMutual Private Wealth & Trust first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
- MassMutual Private Wealth & Trust's Bristol-Myers Squibb position peaked at $4.28M in Q2 2023.
- 954 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.